# Clinical Study on the Efficacy and Safety of SHR-4597 Inhalant in Adult Patients With Asthma

> **NCT06940700** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Guangdong Hengrui Pharmaceutical Co., Ltd** · enrollment: 60 (estimated)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** SHR4597
- **DRUG:** Budesonide inhalant

## Key facts

- **NCT ID:** NCT06940700
- **Lead sponsor:** Guangdong Hengrui Pharmaceutical Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-04
- **Primary completion:** 2025-10
- **Final completion:** 2025-12
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06940700

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06940700, "Clinical Study on the Efficacy and Safety of SHR-4597 Inhalant in Adult Patients With Asthma". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06940700. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*